RBP7 and breast carcinoma: The results showed that RBP7 mRNA expression in ER-positive patients was higher than that in ER-negative patients, and higher expression of RBP7 was associated with better OS and DFS in ER+ breast cancer patients, indicating that RBP7 was mainly related to the prognosis of patients with ER+ breast cancer.